North America Syringes Market Overview and Forecast (2025-2035)
The North America syringes market encompasses the production, distribution, and usage of a diverse range of syringes, including disposable, safety, insulin, prefilled, oral, and glass syringes. Syringes are essential tools in healthcare facilities for drug delivery, vaccination, blood collection, insulin delivery, and a range of aesthetic procedures. With rising incidences of chronic diseases, growing emphasis on safe injection practices, and technological advancements, the market is evolving rapidly. The adoption of smart and safety-engineered syringes is increasing, influenced by regulatory mandates and patient safety considerations. The integration of syringes in digital healthcare, as well as a shift towards needle-free and auto-disable options, further accelerates the market’s transformation. As North America continues its healthcare modernization, the syringes market is poised for sustainable growth.
Latest Market Dynamics
Key Drivers
- Rising prevalence of chronic diseases such as diabetes is fueling demand for syringes, especially insulin syringes. In June 2024, Becton, Dickinson and Company expanded its insulin syringe portfolio to cater to the increasing diabetic population.
- Adoption of safety-engineered and smart syringes is accelerating due to strict regulatory guidelines and the need to minimize needle-stick injuries. Terumo Corporation recently introduced advanced safety syringes targeted at hospitals in the US.
Key Trends
- Integration of digital health technologies with syringes is gaining momentum. Medtronic plc launched smart syringe features compatible with healthcare IoT devices in July 2024.
- Rising preference for prefilled syringes as they reduce medication errors and infection risks. Cardinal Health, Inc. reported a 15% YoY increase in prefilled syringe sales in the first half of 2024.
Key Opportunities
- Expanding vaccination campaigns by governmental and private organizations are driving bulk procurement of disposable syringes. In July 2024, Pfizer collaborated on mass COVID-19 booster drives utilizing BD’s latest syringes.
- Growth in online pharmacies and direct-to-patient distribution channels, supported by Smiths Medical’s June 2024 launch of e-commerce platforms for medical devices.
Key Challenges
- Fluctuations in raw material prices, especially plastics and glass used in syringes, affect manufacturing costs. SCHOTT AG noted increased input costs impacting margins in July 2024.
- Disposal and environmental concerns around single-use plastic syringes, with new regulatory requirements affecting market players. Nipro Corporation reported compliance investments in sustainable product lines in June 2024.
Key Restraints
- Stringent regulatory hurdles delay market entry for innovative syringe technologies. Hamilton Company faced longer-than-expected FDA approvals for smart syringe products in June 2024.
- High initial costs for safety and smart syringes limit adoption, particularly among small healthcare providers. Baxter International Inc. cited capital constraints in mid-2024 during product rollouts.
North America Syringes Market Share by Type (2025)
The syringes market in North America by type is led by disposable syringes, capturing the largest market share owing to their necessity in single-use procedures and infection control. Safety syringes and insulin syringes also maintain significant shares, reflecting the impact of chronic disease management and regulatory focus on patient and personnel safety. The preference for disposable and safety variants continues to rise as healthcare providers emphasize effective infection prevention and compliance with regulatory norms.
North America Syringes Market Share by Application (2025)
Drug delivery remains the dominant application in the North America syringes market, driven by increasing hospital admissions and chronic disease prevalence. Vaccination and insulin delivery also represent substantial shares given intensified immunization programs and the diabetic population respectively. The focus on both routine and emergency applications ensures sustained growth across all main segments, with esthetic procedures and blood collection contributing to diversification.
North America Syringes Market Revenue (USD Million), 2020-2035
The North America syringes market revenue has demonstrated steady growth, with notable acceleration post-2021 following intensified disease management, vaccination drives, and adoption of advanced syringe technologies. The market is projected to expand from $2,250 million in 2021 with an average annual growth rate supporting the anticipated value of $4,200 million by 2035. Factors underpinning this momentum include innovation in safety engineered syringes, growing chronic diseases, and expanding healthcare infrastructure.
North America Syringes Market YOY Growth (%) 2020-2035
Year-on-year growth in the North America syringes market has fluctuated, peaking during major vaccination campaigns and tapering in periods of market adjustment. A notable spike occurred during 2021-2022 tied to COVID-19, but growth stabilized around 6-7% annually by 2025 and is projected to maintain at 5% through 2035 as chronic disease management and technology upgrades continue to drive use.
North America Syringes Market by Region Share (%) 2025
The United States commands the majority share of the syringes market in North America due to its extensive healthcare infrastructure, high procedural volumes, and rapid adoption of safety technologies. Canada maintains a noticeable share, benefitting from universal healthcare and proactive public health initiatives, while Mexico is gradually increasing its market presence with improving healthcare reforms.
North America Syringes Market Players Share (%) 2025
Leading the North America syringes market, Becton, Dickinson and Company accounts for the highest share due to a vast product portfolio and continuous innovation. Cardinal Health, Inc. and Terumo Corporation follow, leveraging strategic partnerships, advanced product lines, and robust distribution networks. Other significant players include B. Braun Melsungen AG and Smiths Medical, contributing to a competitive landscape.
North America Syringes Market Buyers Share (%) 2025
Hospitals & Clinics represent the largest buyer segment, leveraging bulk procurement and regular demand for syringes across multiple medical applications. Retail and online pharmacies are rapidly catching up, spurred by direct-to-patient sales and the convenience of digital health platforms. Wholesalers and drug stores serve as vital distribution nodes for smaller healthcare providers.
Study Coverage
| Metrics | Details |
|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 2750 |
| Regions | US, Canada, Mexico |
| Segments | Disposable Syringes, Safety Syringes, Insulin Syringes, Prefilled Syringes, Oral Syringes, Glass Syringes; Vaccination, Drug Delivery, Blood Collection, Insulin Delivery, Aesthetic Procedures, Others; Hospitals & Clinics, Retail Pharmacies, Online Pharmacies, Drug Stores, Wholesalers, Others; Conventional Syringes, Safety Engineered Syringes, Auto Disable Syringes, Needle-Free Syringes, Smart Syringes, Others; Small, Medium, Large |
| Players | Becton, Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Cardinal Health, Inc., Terumo Corporation, Nipro Corporation, Smiths Medical, Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Retractable Technologies, Inc., Medtronic plc, SCHOTT AG, ICU Medical, Inc., Hamilton Company, Others |
Key Recent Developments
- June 2024: Becton, Dickinson and Company expands insulin syringe production in North America to meet rising diabetes cases.
- July 2024: Medtronic launches smart syringe integration with leading digital health ecosystems.
- June 2024: Smiths Medical debuts an e-commerce portal for direct-to-patient syringe and medical supply sales.
- July 2024: SCHOTT AG announces new eco-friendly glass syringe line to address sustainability goals.
- June 2024: Cardinal Health records double-digit growth in prefilled syringes sales following expanded hospital partnerships.
